Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes

NeuroReport

Volumn 7, Issue 15-17, 1996, Pages 2823-2827

  Bluthé, Rose Marie ^a   Michaud, Bruno ^a   Kelley, Keith W ^b   Dantzer, Robert ^a  

^a INSERM   (France)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Behaviour; Cytokine; Interleukin 1 ; Mouse; Route of injection; Vagus nerve

Indexed keywords

INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMUNE SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VAGOTOMY; VAGUS NERVE;

EID: 0029846289     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199611040-00083     Document Type: Article

References (22)

1. Rothwell NJ and Dantzer R. Interleukin-1 in the Brain. Oxford: Pergamon Press, 1992: 207.
2. Blatteis CM. Yale J Biol Med 63, 133-146 (1990),
3. Gottschall PE, Komaki G and Arimura A. Interleukin-1β activation of the central nervous system. In: Rothwell NJ and Dantzer R (eds) Interleukin-1 in the Brain. Oxford: Pergamon Press, 1992: 27-49. (1992).
4. Stitt JT. Prostaglandin, the OVLT and fever. In: Bartfai T and Ottoson D (eds) Neuro-Immunology of Fever. Oxford: Pergamon Press, 1992: 155-165.
5. Layé S, Parnet P, Goujon E et al. Mol Brain Res 27, 157-162 (1994).
6. Kent S, Bluthé RM, Dantzer R et al. Proc Natl Acad Sci USA 89, 9117-9120 (1992).
7. Kent S, Bluthé RM, Kelley KW et al. Trends Pharmacol Sci 13, 24-28 (1992).
8. Wan W, Wetmore L, Sorensen CM et al. Brain Res Bull 34, 7-14 (1994).
9. Layé S, BluthÈ RM, Kent S et al. Am J Physiol 268, R1327-R1331 (1995).
10. Watkins LR, Goehler LE, Relton JK et al. Neurosci Lett 183, 27-31 (1995).
11. Watkins LR, Maier SF and Goehler LE. Life Sci 67, 1011-1026 (1995).
12. Fleshner M, Goehler LE, Hermann J et al. Brain Res Bull 37, 605-610 (1995).
13. Gaykema RPA, Dijkstra I and Tilders FJH. Endocrinology 136, 4717-4720 (1995).
14. Bluthé RM, Michaud B, Kelley KW I>et al. NeuroReport 7, 1458-1488 (1996).
15. Bret-Dibat JL, Bluthé RM, Kent S et al. Brain Behav Immun 9, 242-246 (1995).
16. Johnson AK and Gross PM. Faseb J7, 678-686 (1993).
17. Bluthé RM, Walter W, Parnet P et al. CR Acad Sci 317, 499-503 (1994).
18. Bluthé RM, Parnet P, Dantzer R et al. Neurosci Res Commun 9, 151-158 (1991).
19. Kiefer R, Lindholm D and Kreutzberg GW. Eur J Neurosci 5, 775-781 (1993).
20. Colosetti P, Olsson T, Miyazono et al. Brain Res Bull 37, 561-567 (1995).
21. Fukuoka H, Kawatani M, Hisamitsu T et al. Brain Res 657, 133-140 (1994).
22. Katsuura G, Gottschall PE. Dahl RR et al. Endocrinology 122, 1773-1779 (1988).